Cosmo Pharma

Cosmo’s diarrhea drug approved, threatening Salix’ cash cow
Pharmaforum
Mon, 11/19/18 - 09:48 am
Cosmo Pharma
FDA
traveller's diarrhea
Aemcolo
Salix
Are small companies carrying the complete response letter can?
EP Vantage
Thu, 05/24/18 - 10:04 pm
FDA
complete response letter
Recro Pharma
Cosmo Pharma
FDA Accepts NDA for Aemcolo (Rifamycin SV MMX) for Travelers' Diarrhea
CP Wire
Mon, 05/21/18 - 06:27 pm
Cosmo Pharma
Aemcolo
traveler's diarrhea
fast track
FDA
FDA Accepts NDA for Aemcolo (Rifamycin SV MMX) for Travelers' Diarrhea
Mon, 05/21/18 - 12:56 pm
Cosmo Pharma
Aemcolo
traveller's diarrhoea
Valeant partner Cosmo turns wannabe IBS-D rival, and it could do some sales damage: analyst
Fierce Pharma
Mon, 01/29/18 - 11:57 pm
Valeant Pharmaceuticals
Cosmo Pharma
rifamycin SV
IBS-d
Xifaxan
Cosmo to Seek More Than $107 Million in Dermatology Unit IPO
Bloomberg
Mon, 06/15/15 - 09:56 am
Cosmo Pharma
dermatology
IPOs
Tougher U.S. Tax Rules Cited as Salix Ends Cosmo Deal
Bloomberg
Fri, 10/3/14 - 07:51 am
Salix
Cosmo Pharma
M&A
Dealpolitik: Unusual Terms in Salix Inversion Invite an Allergan Bid
WSJ Online
Thu, 08/21/14 - 04:27 pm
Salix
Allergan
M&A
Valeant Pharmaceuticals
Cosmo Pharma
Salix Pharmaceuticals: ‘Better Deal Than It Is Being Viewed’
Barron's
Wed, 07/9/14 - 04:59 pm
Salix
Cosmo Pharma
M&A
Salix to Merge With Cosmo in Latest Tax Inversion Deal
Bloomberg
Wed, 07/9/14 - 08:03 am
Salix
Cosmo Pharma
M&A
taxes
Cosmo Scraps Partnership Plans After Santarus Windfall, CEO Says
Bloomberg
Mon, 02/3/14 - 08:29 am
Santarus
Cosmo Pharma
Rifamycin SV MMX
Cosmo Pharma CEO Sees $1.5 Billion Dye Luring Buyer by 2013
Bloomberg
Tue, 09/25/12 - 11:15 am
Cosmo Pharma
M&A
Cosmo Pharma offers to acquire BioXell
Pharmabiz
Sat, 11/21/09 - 12:24 pm
Cosmo Pharma
BioXell
Santarus Collaborates with Cosmo for U.S. Rights to Budesonide MMX and Rifamycin SV MMX
Trading Markets
Sat, 12/20/08 - 11:14 am
Santarus
Cosmo Pharma
Budesonide MMX
Rifamycin SV MMX